Results 71 to 80 of about 21,775 (287)
Topography of geographic atrophy in age-related macular degeneration. [PDF]
PURPOSE: To determine the topographic distribution and progression of geographic atrophy (GA) in patients with AMD. METHODS: Fundus autofluorescence images (excitation 488, emission 500-700 nm) from 413 eyes of 413 subjects (median age, 77.0 ...
Mauschitz MM +9 more
core +1 more source
Towards a Therapy for Geographic Atrophy: A Patient’s Experience
Jamie Enoch,1 Arevik Ghulakhszian,2 Mandeep Sekhon,3 David P Crabb,1 Deanna J Taylor,1 Christiana Dinah2,4 1Department of Optometry and Visual Sciences, City, University of London, London, UK; 2Ophthalmology Department, London North West University ...
Enoch J +5 more
doaj
Genetics of Pigment Changes and Geographic Atrophy
Studies of age-related macular degeneration (AMD) often involve persons with both choroidal neovascularization and geographic atrophy (GA), but few genome-wide scans (GWSs) have discriminated between these two outcomes.To comprehend the role of pigmentary abnormalities (PA) and GA in AMD, the authors analyzed the data from a previous GWS on AMD (FARMS [
Cheryl L, Thompson +6 more
openaire +2 more sources
A closed‐loop direct recycling route for Prussian White sodium‐ion battery cathodes is demonstrated. Ice‐stripped scrap and end‐of‐life electrodes are regenerated via low‐temperature aqueous resodiation (80°C), restoring sodium content, Fe2+ redox chemistry, and structural integrity.
Subha Samanta +8 more
wiley +1 more source
Geographic Atrophy: Pathophysiology, Diagnosis and Current and Emerging Treatments
Background: Geographic atrophy (GA) is an advanced, irreversible form of age-related macular degeneration (AMD) characterised by progressive loss of photoreceptors, retinal pigment epithelium (RPE) and choriocapillaris.
Alexander G. Maloof +6 more
doaj +1 more source
New Treatment Modalities for Geographic Atrophy
Age‑related macular degeneration (AMD) is a significant cause of global visual morbidity and is projected to affect 288 million people by the year 2040. The advent of treatment with anti‒vascular endothelial growth factor (anti‑VEGF) drugs has revolutionized the treatment of neovascular AMD (nAMD) but there have been no similar breakthroughs for the ...
Rathika, Kandasamy +2 more
openaire +2 more sources
The Cost of a Nutritious Diet in Cafeterias: Evidence From US Military Dining Facilities
ABSTRACT Providing nutritious meals in institutional settings with financial constraints, such as military dining facilities, is challenging. The US Department of War (DoW) and US Department of Agriculture (USDA) collaborated to modernize the Basic Daily Food Allowance (BDFA) using an optimization model that incorporates service members' consumption ...
Linlin Fan +8 more
wiley +1 more source
Expert Consensus on Geographic Atrophy in the EU: A Call for Urgent Policy Action
Geographic atrophy is an eye disease that greatly interferes with the daily lives of patients and their families, posing a serious threat to the aging European demographic.
Giuseppe Querques +11 more
doaj +1 more source
Assessing Photovoltaic Recycling Capacities and Policy Gaps in the European Union
This study maps photovoltaic recycling capacity in the EU and key global regions, highlighting gaps between growing waste volumes and available infrastructure. It combines survey insights and policy analysis to identify recycling bottlenecks and offers recommendations to boost circularity in the solar sector.
Nieves Espinosa +3 more
wiley +1 more source
Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the Western world, with a higher prevalence among Europeans and North Americans than that in Africans, Hispanics, and Asians. Advanced AMD is categorized as atrophic
Nithya Boopathiraj, MBBS +4 more
doaj +1 more source

